425: Strive & Semler Scientific Merger: Risks & Outlook

Strive and Semler Scientific provide an update on their proposed business combination, emphasizing forward-looking statements and associated risks.

Summary

• Strive, Inc. and Semler Scientific, Inc. are proceeding with a proposed business combination (merger).
• The communication was reposted on X.com by Pierre Rochard, a Board Member of Strive, Inc., on December 4, 2025.
• The filing serves as a cautionary statement regarding forward-looking statements related to the proposed transaction.
• Strive has filed a Registration Statement on Form S-4, which includes an Information Statement/Proxy Statement/Prospectus, to register Class A common stock to be issued in connection with the merger.
• Stockholders of Semler Scientific will need to approve the proposed transaction.
• Directors, executive officers, and employees of both companies may be involved in the solicitation of proxies from Semler Scientific stockholders.

Sentiment

Score: 4

Explanation: The filing is primarily a cautionary statement regarding a proposed merger, heavily emphasizing numerous risks and uncertainties. While the underlying intent of a merger is generally positive, the document's focus is on potential negative outcomes and challenges, leading to a cautious sentiment score.

Positives

• Anticipated strategic benefits from the proposed transaction.
• Anticipated financial benefits from the proposed transaction, including expected impact on the combined company's future financial performance.
• Expectations for the successful integration of the combined businesses.

Negatives

• The proposed transaction may not close when expected or at all.
• Anticipated benefits, including cost savings and strategic gains, may not be realized.
• Integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The proposed transaction may be more expensive or take longer to complete than anticipated.
• Diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock.
• Potential adverse reactions from Strive's or Semler Scientific's customers or changes to business or employee relationships.
• Changes in Strive's or Semler Scientific's share price before closing could be adverse.

Risks

• The occurrence of any event, change, or other circumstances that could give rise to the right of one or both companies to terminate the merger agreement.
• The possibility that the proposed transaction does not close when expected or at all because conditions to closing are not received or satisfied on a timely basis or at all.
• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company.
• The possibility that anticipated benefits of the proposed transaction, including cost savings and strategic gains, are not realized when expected or at all.
• Risks associated with changes in, or problems arising from, implementation of Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations and their enforcement.
• The possibility that the integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The possibility that the proposed transaction may be more expensive or take longer to complete than anticipated, including as a result of unexpected factors or events.
• The diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships, including those resulting from the announcement or completion of the proposed transaction.
• Changes in Strive's or Semler Scientific's share price before closing.
• Other factors that may affect future results of Strive, Semler Scientific, or the combined company, including unknown or unpredictable factors.

Future Outlook

The future outlook is centered on the successful completion and integration of the proposed business combination between Strive and Semler Scientific, with an expectation of realizing strategic and financial benefits. However, this outlook is heavily qualified by numerous risks and uncertainties, including those related to the timing of closing, integration challenges, cost overruns, and the performance of Bitcoin and other digital assets in treasury strategies.

Management Comments

• Pierre Rochard, Board Member of Strive, Inc., reposted the communication on X.com on December 4, 2025.
• Management of both Strive and Semler Scientific believe their expectations with respect to forward-looking statements are based upon reasonable assumptions within the bounds of existing knowledge of their businesses and operations.

Industry Context

The mention of 'Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets' indicates that the combined entity may be engaging with or exposed to the cryptocurrency market, a notable trend for companies seeking alternative treasury management or investment strategies. This positions the merger within a broader industry context where digital asset integration is becoming a strategic consideration.

Corporate Governance

Stakeholder Impact

• Shareholders of Strive: Potential dilution due to the issuance of additional Class A common stock in connection with the merger.
• Shareholders of Semler Scientific: Will vote on the proposed transaction and will receive Strive Class A common stock if the merger is approved.
• Customers of both companies: Potential for adverse reactions or changes to business relationships resulting from the announcement or completion of the proposed transaction.
• Employees of both companies: Potential for changes to employee relationships resulting from the announcement or completion of the proposed transaction.

Next Steps

• Semler Scientific stockholders will need to approve the proposed transaction.
• Strive and Semler Scientific will continue to work towards satisfying the conditions to closing the proposed transaction.
• Integration of the combined businesses following the closing of the transaction.

Key Dates

Keywords

Strive Inc., Semler Scientific Inc., Merger, Business Combination, SEC Filing, Form 425, Forward-Looking Statements, Risk Factors, Bitcoin Treasury Strategy, Digital Assets, Corporate Governance